Timothy Hatlen to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Timothy Hatlen has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.101
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. Lancet Microbe. 2024 06; 5(6):e559-e569.
Score: 0.053
-
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2023 02; 61(2).
Score: 0.048